Think of the thousands (or tens, or hundreds of thousands)
Think of the thousands (or tens, or hundreds of thousands) whose lives might be saved if Brilacidin and Kevetrin had been rushed through the FDA approval process and were available right now.
And then think of the people who have conspired to suppress stock price, attack the company, and make funding so dilutive for the company because of the low stock price, that the CEO has correctly focused on the cheapest, fastest clinical trials for drugs, rather than spending 30 million dollars to get the Brilacidin-ABSSSI trial completed. And, Kevetrin clinical trials are likewise going much more slowly.
All those who have conspired in this way are murderers. No two ways about it. People have died because of their actions.
This is why I find it particularly abhorrent to have scottsmith identities lamenting the horrible tragedy in Florida. Yes, the school shooting is an unimaginable tragedy and one would have to have a heart of stone not to feel terrible for the families of the victims as well as for those who lost their lives.
But, the hypocrisy of posting about that, while having been involved in activities that have killed many, many more people (through delayed approval of life-saving drugs) -- FOR PERSONAL FINANCIAL GAIN -- well, it just boggles the mind.
Only a sociopath could behave like that.
8
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Market Challenges and Stock Performance Fox Factory Holding Corp (NASDAQ: FOXF) has recently seen its stock sink to a 52-week low, reaching $28.92. This downturn reflects the challenging market conditions the company is currently facing. With a market capitalization of $1.2 billion and a price-to-earnings (P/E) ratio of 113, FOXF now trades below its fair value. Over the...
Continue Reading
Entropy Robotics Partners with SRI for Innovative Navigation Entropy Robotics, an innovative startup focused on AI-driven solutions for robotics and drones, has recently formed a strategic partnership with SRI, an independent nonprofit research organization. This collaboration aims to enhance autonomous navigation capabilities for robots operating in challenging...
Continue Reading
Investment Legal Options for Quanex Building Products Corporation Bronstein, Gewirtz & Grossman, LLC, a leading law firm in investor representation, has announced a significant opportunity for shareholders of Quanex Building Products Corporation (NYSE: NX). Investors who have incurred considerable losses are being invited to participate and potentially lead a class action...
Continue Reading
Braskem's Innovative Sustainability Effort Braskem (B3: BRKM3, BRKM5, and BRKM6; NYSE: BAK) has launched an exciting new sustainable product—bio-circular polypropylene (PP), known as WENEW. As the top producer of polyolefins in the Americas, Braskem is raising the bar by offering this eco-friendly solution specifically designed for the restaurant and snack food...
Continue Reading
Understanding Direxion Daily Semiconductor Bull 3X Shares Direxion Daily Semiconductor Bull 3X Shares (NYSE: SOXL) has delivered impressive returns over the past 15 years, outperforming the general market by a remarkable 29.99% on an annualized basis. The fund boasts an average annual return of 41.86%, showcasing its strength in the technology sector, which continues to...
Continue Reading